ArticleACS chemical neuroscience2025

Discovery of Dual Targeting GSK-3β/HIV-1 Reverse Transcriptase Inhibitors as Neuroprotective Antiviral Agents.

Thane Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.